A DOCK1 INHIBITOR CAN INCREASE THE SENSITIVITY OF CYTARABINE ON DOCK1 OVEREXPRESSED ACUTE MYELOID LEUKEMIA CELL LINE

被引：0
|
作者：
Yoshitomi, Masahiro [1 ]
Ikeda, Junji [1 ]
Tsujimoto, Shinichi [1 ,2 ]
Ito, Shuichi [1 ]
Hasegawa, Daisuke [2 ]
Iwamoto, Shotaro [2 ]
Hayashi, Yasuhide [3 ]
Adachi, Souichi [2 ]
Tomizawa, Daisuke [2 ]
Shiba, Norio [1 ,2 ]
机构：
[1] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan
[2] JCCG, Tokyo, Japan
[3] Jobu Univ, Inst Physiol & Med, Gunma, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS1-5
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [21] Actin Up: An Overview of the Rac GEF Dock1/Dock180 and Its Role in Cytoskeleton Rearrangement
    Koubek, Emily J.
    Santy, Lorraine C.
    CELLS, 2022, 11 (22)
  • [22] 大鼠非梗死区心肌Dock1蛋白表达改变
    刘小兰
    赵文菊
    李刚
    王志华
    王丽平
    第二军医大学学报, 2012, 33 (05) : 540 - 543
  • [23] Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1
    Tajiri, Hirotada
    Uruno, Takehito
    Shirai, Takahiro
    Takaya, Daisuke
    Matsunaga, Shigeki
    Setoyama, Daiki
    Watanabe, Mayuki
    Kukimoto-Niino, Mutsuko
    Oisaki, Kounosuke
    Ushijima, Miho
    Sanematsu, Fumiyuki
    Honma, Teruki
    Terada, Takaho
    Oki, Eiji
    Shirasawa, Senji
    Maehara, Yoshihiko
    Kang, Dongchon
    Cote, Jean-Francois
    Yokoyama, Shigeyuki
    Kanai, Motomu
    Fukui, Yoshinori
    CELL REPORTS, 2017, 19 (05): : 969 - 980
  • [24] DOCK1 as a novel target for controlling RAS-driven cancer cell survival and invasion.
    Uruno, Takehito
    Fukui, Yoshinori
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 59 - 59
  • [25] TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT
    Chen, Xin
    Zhou, Zhenbang
    Tang, Pengting
    Du, Feiya
    Wang, Shuqian
    Yao, Jia
    Zhang, Shufen
    Huang, Jiajing
    Lu, Xuemei
    Chen, Wei
    Yu, Xiaofang
    Liu, Yu
    Liu, Hao
    CURRENT CANCER DRUG TARGETS, 2025, 25 (01) : 72 - 82
  • [26] High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
    Yoshitomi, Masahiro
    Tsujimoto, Shin-Ichi
    Ikeda, Junji
    Kawai, Tomoko
    Ohki, Kentaro
    Hara, Yusuke
    Yamato, Genki
    Tanoshima, Reo
    Tomizawa, Daisuke
    Shimada, Akira
    Horibe, Keizo
    Adachi, Souichi
    Taga, Takashi
    Tawa, Akio
    Hayashi, Yasuhide
    Ito, Shuichi
    Shiba, Norio
    PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
  • [27] DOCK1 deficiency drives placental trophoblast cell dysfunction by influencing inflammation and oxidative stress, hallmarks of preeclampsia
    Xu, Yichi
    Qin, Xiaoli
    Zeng, Weihong
    Wu, Fan
    Wei, Xiaowei
    Li, Qian
    Lin, Yi
    HYPERTENSION RESEARCH, 2024, 47 (12) : 3434 - 3446
  • [28] A role for the myoblast city homologues Dock1 and Dock5 and the adaptor proteins Crk and Crk-like in zebrafish myoblast fusion
    Moore, Catherine A.
    Parkin, Caroline A.
    Bidet, Yannick
    Ingham, Philip W.
    DEVELOPMENT, 2007, 134 (17): : 3145 - 3153
  • [29] Wnt5a induces ROR1 to associate with DOCK1 and promote growth of breast cancer
    Hasan, Md Kamrul
    Tripple, Victoria
    Widhopf, George F.
    Zhang, Suping
    Parker, Barbara A.
    Kipps, Thomas J.
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Phosphatidic Acid-dependent Recruitment and Function of the Rac Activator DOCK1 during Dorsal Ruffle Formation
    Sanematsu, Fumiyuki
    Nishikimi, Akihiko
    Watanabe, Mayuki
    Hongu, Tsunaki
    Tanaka, Yoshihiko
    Kanaho, Yasunori
    Cote, Jean-Francois
    Fukui, Yoshinori
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (12) : 8092 - 8100
12345